Advances in Antimalarial Drugs

Antimalarial medications, also known as antimalarials, are designed to prevent or cure malaria. Antimalarial drugs may be used for the treatment of malaria in individuals with suspected or confirmed infection, for the prevention of infection in individuals visiting a malaria-endemic region who have no immunity (Malaria prophylaxis) and for the Routine intermittent treatment of certain groups in endemic regions (Intermittent preventive therapy). Some antimalarial agents, particularly chloroquine and hydroxychloroquine, are also used in the treatment of rheumatoid arthritis and lupus-associated arthritis.

 

In the present book, twelve typical literatures about antimalarial drugs published on international authoritative journals were selected to introduce the worldwide newest progress, which contains reviews or original researches on medical science, virology, epidemiology, ect. We hope this book can demonstrate advances in antimalarial drugs as well as give references to the researchers, students and other related people.

Components of the Book:
  • Chapter 1
    Malaria Eradication and Elimination: Views on How to Translate a Vision into Reality
  • Chapter 2
    A Genomic and Evolutionary Approach Reveals Non-Genetic Drug Resistance in Malaria
  • Chapter 3
    Development of Cultured Plasmodium Falciparum Blood-Stage Malaria Cell Banks for Early Phase in Vivo Clinical Trial Assessment of Anti-Malaria Drugs and Vaccines
  • Chapter 4
    Mass Campaigns with Antimalarial Drugs: A Modelling Comparison of Artemether-Lumefantrine and DHA-Piperaquine with and without Primaquine as Tools for Malaria Control and Elimination
  • Chapter 5
    Measuring Windows of Selection for Anti-Malarial Drug Treatments
  • Chapter 6
    Predictive Modeling of Anti-Malarial Molecules Inhibiting Apicoplast Formation
  • Chapter 7
    Spectrophotometric Detection of Susceptibility to Anti-Malarial Drugs
  • Chapter 8
    Assessing the Quality of Anti‑Malarial Drugs from Gabonese Pharmacies Using the MiniLab®: A Field Study
  • Chapter 9
    Identifying Rapidly Parasiticidal Anti-Malarial Drugs Using a Simple and Reliable in Vitro Parasite Viability Fast Assay
  • Chapter 10
    Assessment of Therapeutic Responses to Gametocytocidal Drugs in Plasmodium Falciparum Malaria
  • Chapter 11
    Fake Anti‑Malarials: Start with the Facts
  • Chapter 12
    Phytochemical Screening and in Vivo Antimalarial Activity of Extracts from Three Medicinal Plants Used in Malaria Treatment in Nigeria
Readership: Students, academics, teachers and other people attending or interested in Advances in Antimalarial Drugs
Marcel Tanner
Swiss Tropical & Public Health Institute, University of Basel, Basel, Switzerland

Jonathan D. Herman
Department of Immunology and Infectious Disease, Harvard School of Public Health, Boston, USA

Danielle I. Stanisic
Institute for Glycomics, Griffith University, Southport, Australia

Katherine Kay
Parasitology Group, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, UK

Benjamin J. Visser
Division of Internal Medicine, Department of Infectious Diseases, Center of Tropical Medicine and Travel Medicine, University of Amsterdam, Amsterdam, The Netherlands

Elizabeth A. Ashley
Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK

and more...
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top